Lyka Labs Limited has informed the Exchange regarding Appointment of Mr Gajanan as Other of the company w.e.f. July 03, 2025.
LYKALABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lyka Labs Limited has appointed Mr. Gajanan Karkamkar as Vice President – Quality Assurance with effect from July 3, 2025. Mr. Karkamkar brings over 39 years of experience in quality and regulatory functions across the pharmaceutical industry. He has previously worked with reputed companies including Cipla Limited, Wockhardt Limited, Macleods Pharmaceutical Limited, and Ajanta Pharma Limited. In his new role, he will oversee the company's Quality Assurance strategy, ensure compliance with industry standards, and collaborate with R&D, Manufacturing, Regulatory, and Operations teams. The disclosure was made under SEBI Listing Regulations as a senior management personnel change.
This is a routine senior management appointment with no immediate material impact on shareholders. Strengthening the quality assurance leadership could support regulatory compliance and operational standards, which is relevant for a pharma company, but it does not directly affect earnings or stock price in the short term.